GripAble gadget tested for spasticity rehab after botox shots
NCT ID NCT05169775
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at whether a device called GripAble can help doctors and patients track the effects of Botox injections for arm muscle stiffness. Sixteen people with upper limb spasticity used the tool at home and during clinic visits. The goal was to see if it could measure changes in muscle tightness and help with rehabilitation exercises.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- GripAble (rehabilitation device)
- What this could lead to
- If successful, this could show that a simple home device helps track and improve recovery between Botox injections for muscle stiffness.
- What could go wrong
- This is a very small, observational study with only 16 participants. It is not designed to prove the device works, only to explore its potential use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
16 people
The number who actually took part.
- Started
-
Mar 2022
- Finished
-
Jan 2023
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
1 secondary care center in the UK.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with hemiparesis with spasticity in the Primary Target Muscle Group (PTMG) for whom a decision to treat with BoNT-A has been made prior to inclusion in the study * BoNT-A injection must be administered in the PTMG; injection into additional upper limb muscles must be based on investigator's judgment in line with the relevant Summary of Product Characteristics (SmPC) * Naïve or non-naïve to BoNT-A treatment; if non-naïve, at least 4months elapsed after the last BoNT-A injection, of any marketed formulation prescribed in accordance to the relevant SmPC * Must be able to use the GripAble tool and have access to the internet through wireless connection in the home setting * Patients for whom the use of the GripAble tool aims to train: 1. Wrist extension, 2. Supination, 3. Grip and release Exclusion Criteria: * Surgery on any upper limb or intrathecal baclofen therapy (ITB) for spasticity within the last 3 months * Progressive neurological (e.g. Parkinson's Disease) * Patients with no active muscle recruitment in the affected upper limb * Patients with significant cognitive impairment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Upper limb spasticity (ULS) are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hull University Teaching Hospital NHS Trust
Hull, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.